keyword
MENU ▼
Read by QxMD icon Read
search

Bupropione

keyword
https://www.readbyqxmd.com/read/30230570/severe-bupropion-xr-abuse-in-a-patient-with-long-standing-bulimia-nervosa-and-complex-ptsd
#1
Yael Dagan, Joel Yager
OBJECTIVE: Although abuse of bupropion to achieve euphoria or a stimulant-like effect has been described in the literature, to our knowledge abuse of bupropion XR to control binge eating and reduce appetite by a patient with eating disorder has not been previously reported. METHOD: We report the case of a 22-year-old woman with bulimia nervosa and complex PTSD who abused bupropion XR to doses that at peak reached 3,000-4,500 mg/day. She suffered from adverse effects including headaches, tachycardia, anxiety, insomnia, and, finally, grand mal seizures...
September 19, 2018: International Journal of Eating Disorders
https://www.readbyqxmd.com/read/30222626/drug-induced-cutaneous-lupus-erythematosus-a-case-series-of-five-patients-with-bupropion-associated-disease
#2
Claire E Hannah, Anthony J Little, Karolyn A Wanat, Janet A Fairley
No abstract text is available yet for this article.
September 14, 2018: Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases
https://www.readbyqxmd.com/read/30219678/metabolism-of-liver-cyp450-and-ultrastructural-changes-after-long-term-administration-of-aspirin-and-ibuprofen
#3
Congcong Wen, Zaishou Zhuang, Huanchun Song, Shuhua Tong, Xianchuan Wang, Yijing Lin, Haichao Zhan, Zhibin Chen, Lufeng Hu
Worldwide, aspirin and ibuprofen are the most commonly used non-steroidal anti-inflammatory drugs (NSAIDs). Some adverse reactions, including gastrointestinal reactions, have been concerned extensively. Nevertheless, the mechanism of liver injury remains unclear. In the present study, we focused on the metabolism of liver cytochrome P450 (CYP450) and ultrastructural morphology of liver cells. A total of thirty rats were divided into three groups of 10. Rats in the aspirin and ibuprofen groups were given enteric-coated aspirin (15 mg/kg) and ibuprofen (15 mg/kg), respectively by gavage for four weeks...
September 13, 2018: Biomedicine & Pharmacotherapy, Biomédecine & Pharmacothérapie
https://www.readbyqxmd.com/read/30209803/pharmacotherapy-of-obesity-state-of-the-art
#4
Beata Matyjaszek-Matuszek, Aneta Szafraniec, Dominik Porada
Obesity, which affects about 13% of the world population, results in significant deterioration of health and serious clinical, mainly meta-bolic and cardiovascular complications. Although the basis of therapeutic treatment is behavioural treatment, often non-pharmacological effects do not produce the desired effect. Currently there are several drugs with a safe action profile that improve the effect of treatment (5-10% weight reduction). The aim of the paper is to present the potential of modern pharmacotherapy in the treatment of obesity, in terms of mechanism of action, efficacy, and side effects, in order to individualise therapy...
2018: Endokrynologia Polska
https://www.readbyqxmd.com/read/30194544/other-antidepressants
#5
T E Schwasinger-Schmidt, M Macaluso
This chapter addresses the following FDA-approved medications for the treatment of major depressive disorder available for use in the United States including bupropion, mirtazapine, trazodone, vortioxetine, and vilazodone. These medications do not belong to one of the previously featured classes of antidepressants discussed in the preceding chapters. Each medication featured in this chapter has a unique structure and properties that target diverse receptors in the central nervous system. These diverse targets are distinct from other classes of medications used to treat major depressive disorder...
September 8, 2018: Handbook of Experimental Pharmacology
https://www.readbyqxmd.com/read/30176966/respiratory-related-leg-movements-of-sleep-are-associated-with-serotonergic-antidepressants-but-not-bupropion
#6
Catherine A McCall, John W Winkelman
STUDY OBJECTIVES: Respiratory-related leg movements (RRLMs) may contribute to the cardiovascular risk associated with obstructive sleep apnea (OSA). Selective serotonin reuptake inhibitors (SSRIs), but not bupropion, increase periodic leg movements in sleep. This study examines whether patients with OSA using SSRIs have more RRLMs than those taking bupropion or no antidepressant. METHODS: Patients with an apnea-hypopnea index (AHI) of at least 10 events/h during a full-night diagnostic study or split-night study, who were taking bupropion (n = 32), an SSRI (n = 31), or no antidepressant (n = 31), were selected from a database of prestudy questionnaires...
August 30, 2018: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://www.readbyqxmd.com/read/30166913/simultaneous-determination-of-naltrexone-and-bupropion-in-their-co-formulated-tablet-utilizing-green-chromatographic-approach-with-application-to-human-urine
#7
Sherif A Abdel-Gawad, Rania M El-Gamal
A rapid, simple and accurate micellar HPLC-method was adopted and validated for concurrent quantification of naltrexone hydrochloride (NTX) and bupropion hydrochloride (BUP). The proposed method was conducted on RP-18 LiChrosorb® column (150 mm × 4.6 mm i.d. 5-µm particle size) at 25 °C, as a stationary phase and a mixture of 0.175 M sodium dodecyl sulphate (SDS), 0.3% triethanolamine (TEA) and 12% n -propanol in 0.02 M ortho (o)- phosphoric acid of pH 3.5 as a developing system. It was pumped at a flow rate of 1...
February 2018: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://www.readbyqxmd.com/read/30155394/development-of-oral-candidiasis-following-initiation-and-rechallenge-of-extended-release-bupropion-in-a-geriatric-patient
#8
Nina Vadiei, Tawny L Smith, Erica C Garcia-Pittman
Objective: To report a case of oral candidiasis that developed in a 70-year-old white female both upon initiation and rechallenge of extended-release bupropion therapy. Case Summary: A 70-year-old female with a past medical history of osteoarthritis, degenerative joint disease, and polycythemia vera developed oral candidiasis on 2 occasions following initiation of extended-release bupropion for the treatment of recurrent depression. During both instances, the reaction occurred with an increased dose of the medication, suggesting the adverse event may have been dose-related...
July 2018: The mental health clinician
https://www.readbyqxmd.com/read/30148931/-sustained-upgaze-in-a-patient-who-ingested-high-doses-of-bupropion-report-of-one-case
#9
Luis Cartier R, Cristian Romero O, Gerardo Pérez P
Upgaze or sustained elevation of the eyes, is an alteration of ocular motility initially described in hypoxic coma. We report a 65-year-old woman admitted with hypotension and alteration of sensorium due to the ingestion of 9.5 g of Bupropion. She presented two seizures of short duration, without epileptic activity on the EEG. She had a persistent asynchronous myoclonus in extremities, tachycardia and prolonged Q-t. She suffered a cardiac arrest caused by asystole, which recovered quickly in five minutes. At that moment, upgaze appeared, associated with a persistent ocular opening, which persisted for days, but finally disappeared, without remission of coma...
May 2018: Revista Médica de Chile
https://www.readbyqxmd.com/read/30139432/prevention-and-treatment-of-tobacco-use-jacc-health-promotion-series
#10
REVIEW
Sara Kalkhoran, Neal L Benowitz, Nancy A Rigotti
Tobacco use is the leading preventable cause of death worldwide and is a major risk factor for cardiovascular disease (CVD). Both prevention of smoking initiation among youth and smoking cessation among established smokers are key for reducing smoking prevalence and the associated negative health consequences. Proven tobacco cessation treatment includes pharmacotherapy and behavioral support, which are most effective when provided together. First-line medications (varenicline, bupropion, and nicotine replacement) are effective and safe for patients with CVD...
August 28, 2018: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/30135556/do-baseline-sub-threshold-hypomanic-symptoms-affect-acute-phase-antidepressant-outcome-in-outpatients-with-major-depressive-disorder-preliminary-findings-from-the-randomized-co-med-trial
#11
Manish K Jha, Ashley L Malchow, Bruce D Grannemann, A John Rush, Madhukar H Trivedi
Sub-threshold hypomanic symptoms are common in major depressive disorder. This study evaluated the prevalence, the clinical and sociodemographic correlates, and the overall and differential effects of the presence/absence of sub-threshold hypomanic symptoms at baseline on acute-phase treatment outcomes with bupropion-plus-escitalopram combination, escitalopram monotherapy, and venlafaxine-plus-mirtazapine combination. Combining medications to enhance depression outcomes (CO-MED) trial participants (n = 665) were designated as sub-threshold hypomanic symptoms present (Altman Self-Rating Mania Scale score (ASRM) ≥ 1) or absent (ASRM = 0) and compared on clinical and sociodemographic features and remission rates...
October 2018: Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology
https://www.readbyqxmd.com/read/30131174/antidepressants-in-epilepsy
#12
REVIEW
Natalia Górska, Jakub Słupski, Wiesław Jerzy Cubała, Mariusz Stanisław Wiglusz, Maria Gałuszko-Węgielnik
People with epilepsy (PWE) frequently suffer from comorbid mood and anxiety disorders. Depression is one of the major psychiatric comorbidities having a negative impact on the quality of life in people with epilepsy. A review of the literature indicates that the majority of antidepressant-related seizures have been associated with either ultra-high doses or overdosing and, generally, the risk of antidepressant-associated seizures is low. Correspondingly, there is some evidence indicating that antidepressants of most widely used groups may additionally lower the risk of triggering seizures...
August 11, 2018: Neurologia i Neurochirurgia Polska
https://www.readbyqxmd.com/read/30121536/assessment-of-83-pharmaceuticals-in-wwtp-influent-and-effluent-samples-by-uhplc-ms-ms-hourly-variation
#13
Paula Paíga, Manuela Correia, Maria João Fernandes, Ana Silva, Manuela Carvalho, Joana Vieira, Sandra Jorge, Jaime Gabriel Silva, Cristina Freire, Cristina Delerue-Matos
The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency close to 100%. Their incomplete removal results in a continuous discharge of pharmaceuticals into the environment. To assess the profile of contamination of influents and effluents over a day, a set of 83 pharmaceuticals were evaluated hourly in a WWTP in Leiria, Portugal. The composite samples of the influent and effluent were also collected...
August 10, 2018: Science of the Total Environment
https://www.readbyqxmd.com/read/30117332/-ghost-tablet-husks-excreted-in-feces-in-large-bupropion-xl-overdose
#14
Adam Overberg, Andrea Purpura, Kristine Nanagas
BACKGROUND: Extended-release medications are widely prescribed across the spectrum of medical specialties; however, there is heterogeneity in how they are formulated. Commonly, they consist of an insoluble matrix or shell from which drug elutes, which may then be observed by patients when excreted in feces. We describe the case of a patient who ingested a large amount of extended-release bupropion tablets and subsequently passed a large number of these so-called "ghost tablets" in his stool...
August 17, 2018: Clinical Toxicology
https://www.readbyqxmd.com/read/30112578/an-exploration-of-the-aversive-properties-of-2-deoxy-d-glucose-in-rats
#15
Thomas Horman, Maria Fernanda Fernandes, Yan Zhou, Benjamin Fuller, Melissa Tigert, Francesco Leri
Hypoglycemia can alter arousal and negatively impact mood. This study tests the hypothesis that acute drops in glucose metabolism cause an aversive state mediated by monoamine activity. In experiment 1, male Sprague-Dawley rats were either food deprived (FD) or pre-fed (PF) and tested on conditioned place avoidance (CPA; biased place conditioning design; 3 pairings drug/vehicle, each 30 min-long) induced by the glucose antimetabolite 2-deoxy-D-glucose (2-DG; 0, 300 or 500 mg/kg, SC). Locomotion and blood glucose were also assessed...
August 15, 2018: Psychopharmacology
https://www.readbyqxmd.com/read/30105744/patient-understanding-of-the-neuropsychiatric-risks-associated-with-branded-bupropion-hydrochloride-products-used-for-smoking-cessation
#16
John Ascher, Annette Stemhagen, Monika Stender, Beta Win, Christina Winter
BACKGROUND: Bupropion hydrochloride (Zyban) is an effective aid to smoking cessation; however, its use has previously been associated with neuropsychiatric adverse events. Here we report results of the patient Knowledge, Attitudes, and Behavior survey that forms part of the Year 7 Risk Evaluation and Mitigation Strategy (REMS) assessment for Zyban. OBJECTIVE: Assess participants' understanding of the neuropsychiatric risks associated with branded bupropion hydrochloride products that are used for smoking cessation, as described in the Medication Guides...
September 2018: Drugs—Real World Outcomes
https://www.readbyqxmd.com/read/30103176/bupropion-attenuates-morphine-tolerance-and-dependence-possible-role-of-glutamate-norepinephrine-inflammation-and-oxidative-stress
#17
Mostafa Mahmoud Hamdy, Mohamed Mostafa Elbadr, Ahmed Barakat
BACKGROUND: Morphine - the main pillar of nociceptive pain management - systemic use is associated with development of tolerance and dependence. Tolerance and dependence lay a heavy burden in clinical pain management settings. An added weight to this dilemma is that effective, safe, and tolerable solution to this problem is still beyond reach. Antidepressants were reported as possible alleviators of opioid tolerance and dependence. One of the increasingly used antidepressant in clinical practice is bupropion given its high safety and tolerability profile...
April 11, 2018: Pharmacological Reports: PR
https://www.readbyqxmd.com/read/30099340/methanolic-extract-of-morinda-citrifolia-linn-unripe-fruit-attenuates-methamphetamine-induced-conditioned-place-preferences-in-mice
#18
Vijayapandi Pandy, Yew Chang Wai, Nurul Fatin Amira Roslan, Arif Sajat, Abdulla Hamid Abdulla Jallb, Kamini Vijeepallam
The first objective of the present study was to determine the appropriate dose of methamphetamine (Meth) to induce a successful conditioned place preference (CPP) in mice. The next objective was to examine the effect of a methanolic extract of M. citrifolia unripe fruit (MMC) against Meth-induced CPP in mice. In answering to the first objective, following the preconditioning test, an intraperitoneal injection of a fixed dose of Meth (0.5 or 1 or 2 mg/kg, i.p.) or saline (10 ml/kg, i.p.) was given on alternate days during the 10 days conditioning period followed by a postconditioning test conducted in Meth-free state...
August 9, 2018: Biomedicine & Pharmacotherapy, Biomédecine & Pharmacothérapie
https://www.readbyqxmd.com/read/30097390/comparative-efficacy-and-tolerability-of-medications-for-attention-deficit-hyperactivity-disorder-in-children-adolescents-and-adults-a-systematic-review-and-network-meta-analysis
#19
Samuele Cortese, Nicoletta Adamo, Cinzia Del Giovane, Christina Mohr-Jensen, Adrian J Hayes, Sara Carucci, Lauren Z Atkinson, Luca Tessari, Tobias Banaschewski, David Coghill, Chris Hollis, Emily Simonoff, Alessandro Zuddas, Corrado Barbui, Marianna Purgato, Hans-Christoph Steinhausen, Farhad Shokraneh, Jun Xia, Andrea Cipriani
BACKGROUND: The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain controversial, and guidelines are inconsistent on which medications are preferred across different age groups. We aimed to estimate the comparative efficacy and tolerability of oral medications for ADHD in children, adolescents, and adults. METHODS: We did a literature search for published and unpublished double-blind randomised controlled trials comparing amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with each other or placebo...
September 2018: Lancet Psychiatry
https://www.readbyqxmd.com/read/30092919/pharmacologic-treatment-of-perinatal-depression
#20
REVIEW
Mary C Kimmel, Elizabeth Cox, Crystal Schiller, Edith Gettes, Samantha Meltzer-Brody
This review provides information about medications used to treat perinatal depression, including guidance around when to use certain medications and when to consult a mental health provider. For each group of medications, including selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, mirtazapine, bupropion, lithium, atypical antipsychotics, and lamotrigine, the risks and benefits of treatment during pregnancy and lactation are reviewed, and unique qualities of each medication...
September 2018: Obstetrics and Gynecology Clinics of North America
keyword
keyword
109274
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"